Increased leukotrienes in exhaled breath condensate in childhood asthma

Am J Respir Crit Care Med. 2002 Nov 15;166(10):1345-9. doi: 10.1164/rccm.200203-233OC. Epub 2002 Sep 5.

Abstract

Cysteinyl leukotrienes (cys-LTs; LTC4, LTD4, and LTE4) are generated predominantly by mast cells and eosinophils and induce airway smooth muscle contraction, microvascular leakage, and mucous hypersecretion whereas leukotriene B4 (LTB4) is a potent chemoattractant of neutrophils. We measured cys-LTs and LTB4 in exhaled breath condensate from children aged 7-14 years including healthy nonatopic children (n = 11) and children with mild intermittent asthma (steroid naive, n = 11), mild persistent asthma (low-dose inhaled steroid treatment, n = 13), or moderate to severe persistent asthma (high-dose inhaled steroid treatment, n = 13). Exhaled LTB4 levels were increased in patients with mild and moderate to severe persistent asthma compared with patients with mild intermittent asthma (126.0 +/- 8.8 and 131.9 +/- 7.1 versus 52.7 +/- 3.8 pg/ml, p < 0.001 and p < 0.0001) and normal subjects (126.0 +/- 8.8 and 131.9 +/- 7.1 versus 47.9 +/- 4.1 pg/ml, p < 0.0001). Elevated exhaled cys-LT levels were found in patients with mild and moderate to severe persistent asthma compared with normal subjects (27.9 +/- 2.8 and 31.5 +/- 4.5 versus 18.5 +/- 0.5 pg/ml, p < 0.01 and p < 0.05). There was an inverse correlation between exhaled cys-LTs and LTB4 in patients with mild persistent asthma. We conclude that exhaled cys-LTs and LTB4 may be noninvasive markers of airway inflammation in pediatric asthma.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Asthma / drug therapy
  • Asthma / metabolism*
  • Biomarkers
  • Breath Tests*
  • Child
  • Child Welfare
  • Cysteine / metabolism*
  • Female
  • Forced Expiratory Volume / physiology
  • Humans
  • Leukotriene B4 / metabolism*
  • Leukotrienes / metabolism*
  • Male
  • Nitric Oxide / metabolism
  • Respiration* / drug effects
  • Severity of Illness Index
  • Statistics as Topic
  • Steroids, Fluorinated / therapeutic use
  • Treatment Outcome
  • United Kingdom

Substances

  • Biomarkers
  • Leukotrienes
  • Steroids, Fluorinated
  • cysteinyl-leukotriene
  • Leukotriene B4
  • Nitric Oxide
  • Cysteine